(Boursier.com) — Sales of Boiron over the half-year increased by 35.2%. The increase is split more or less evenly between historical homeopathic specialties and new products.
As for new products, launched since 2020, their sales amounted to around 47 ME over this half-year compared to 15 ME over the first half of 2021.
Given the significant increase in activity and the effect of the reorganization carried out in France, Boiron expects operating income to rise sharply in the first half.
Cumulatively over the year, the company expects an increase in turnover and profitability compared to 2021.
©2022 Boursier.com